enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. CRISPR gene editing - Wikipedia

    en.wikipedia.org/wiki/CRISPR_gene_editing

    CRISPR gene editing (CRISPR, pronounced / ˈ k r ɪ s p ə r / (crisper), refers to a clustered regularly interspaced short palindromic repeats") is a genetic engineering technique in molecular biology by which the genomes of living organisms may be modified.

  3. CRISPR - Wikipedia

    en.wikipedia.org/wiki/CRISPR

    Cas9 (or "CRISPR-associated protein 9") is an enzyme that uses CRISPR sequences as a guide to recognize and open up specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within living organisms.

  4. How CRISPR is tackling the troubling immune response ... - AOL

    www.aol.com/crispr-tackling-troubling-immune...

    One of the major challenges facing gene therapy — a way to treat disease by replacing a patient’s defective genes with healthy ones — is that it is difficult to safely deliver therapeutic ...

  5. Hazards of synthetic biology - Wikipedia

    en.wikipedia.org/wiki/Hazards_of_synthetic_biology

    However, synthetic biology could expand the group of people with relevant capabilities, and reduce the amount of time needed to develop them. [6]: 2–7 A 2018 National Academies of Sciences, Engineering, and Medicine (NASEM) report identified three capabilities as being of greatest concern.

  6. He Jiankui affair - Wikipedia

    en.wikipedia.org/wiki/He_Jiankui_affair

    On 26 November 2018, The CRISPR Journal published ahead of print an article by He, Ryan Ferrell, Chen Yuanlin, Qin Jinzhou, and Chen Yangran in which the authors justified the ethical use of CRISPR gene editing in humans. [74] As the news of CRISPR babies broke out, the editors reexamined the paper and retracted it on 28 December, announcing:

  7. Is Crispr Therapeutics Stock a Bad News Buy? - AOL

    www.aol.com/news/crispr-therapeutics-stock-bad...

    Here's why. After the FDA put the company's gene-editing product candidate for sickle cell disease on hold, bargain hunters may want to scoop up some shares. Here's why.

  8. Human germline engineering - Wikipedia

    en.wikipedia.org/wiki/Human_germline_engineering

    Human germline engineering (HGE) is the process by which the genome of an individual is modified in such a way that the change is heritable. This is achieved by altering the genes of the germ cells, which mature into eggs and sperm.

  9. Biotechnology risk - Wikipedia

    en.wikipedia.org/wiki/Biotechnology_risk

    Since then, new technologies like CRISPR and gene drives have been introduced. While the ability to deliberately engineer pathogens has been constrained to high-end labs run by top researchers, the technology to achieve this is rapidly becoming cheaper and more widespread. [ 4 ]